| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.07 | 0.4 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |